Kre1p is a cell surface O-glycoprotein involved in a late stage of 1,6-b-glucan formation in the yeast Saccharomyces cerevisiae. Disruption of KRE1 leads to a 40 % reduction in the overall 1,6-b-glucan content of the cell wall. This paper shows that in a yeast Dkre1 null mutant, neither an N-terminal-truncated Kre1p nor Kre1p variants lacking a C-terminal glycosylphospatidylinositol (GPI) attachment site are capable of achieving normal function in glucan assembly, while full-length Kre1p completely complements a Dkre1 null mutation and restores cell wall 1,6-b-glucan content up to wild-type level. In a yeast gpi1 mutant, a green-fluorescent-protein-tagged Kre1p derivative is secreted into the medium, indicating an at least transient GPI-anchoring stage of Kre1p during its processing within the yeast secretory pathway. In contrast to the severe defect in cell wall b-D-glucan, the amount of cell wall mannoproteins is not significantly decreased in a Dkre1 disruptant, as could be confirmed in competition assays by investigating toxin binding to isolated cell wall mannoproteins. Since the yeast Dkre1 mutant differed in its sensitivity to zygocin and K28, two killer viral protein toxins that use different cell wall mannoprotein populations as a primary toxin receptor, it can be concluded that in a yeast Dkre1 background, mannoproteins do not differ significantly in total amount from a Kre1 + wild-type but rather in their expression and distribution at the cell surface. Taken together, these data favour and suggest a structural, rather than enzymic, function of Kre1p in yeast cell wall assembly.
INTRODUCTION
Binding of yeast killer toxins to defined components of the Saccharomyces cerevisae cell wall provides a valuable means of identifying genes that are involved in the biosynthesis and/or structure of particular cell wall components (Cid et al., 1995) . In particular, binding of yeast killer toxin K1 to cell wall 1,6-b-glucans has allowed the identification of a number of genes that are essential for glucan synthesis, while the localization of their gene products within the secretory pathway provided further insight into the synthesis and assembly of this important yeast cell 'organelle' (Brown et al., 1993) . In yeast kre mutants (indicating killer resistant), the binding of the K1 toxin to the cell wall is blocked either by disturbing the synthesis or by altering the structure of cell wall 1,6-b-glucans (recently reviewed by . Just as K1 has been successfully employed for the selection of toxin-resistant mutants defective in various steps of cell wall 1,6-b-D-glucan biosynthesis, the viral K28 toxin is a powerful tool for investigating cell wall mannoprotein structure, synthesis and function since it uses a high-molecular-mass cell wall mannoprotein as a primary receptor . Thus, mutations in different chromosomal MNN genes, whose gene products are directly or indirectly involved in mannoprotein synthesis and/or side-chain structure, lead to a K28 toxin resistance at the cell wall level (Tipper & Schmitt, 1991) .
Yeast KRE1 encodes a serine/threonine-rich, highly Oglycosylated protein of the cell surface that is involved in a late stage of the synthesis and/or assembly of yeast cell wall 1,6-b-D-glucan (Boone et al., 1990) . In a Dkre1 null mutant, the total amount of cell wall 1,6-b-glucan is 40 % lower than in the wild-type and the resulting glucan polymer shows a lower degree of polymerization and possesses significantly fewer b-1,3-glycosidic branches. It has been speculated that during its secretion Kre1p is glycosylphospatidylinositol (GPI)-anchored via its C-terminal hydrophobic part, but so far this hypothesis has not clearly been proven. Recently, the membrane-bound form of Kre1p has been shown to function as a plasma membrane receptor for the yeast K1 killer toxin . Here, we extend our previous finding by investigating Kre1p with 3Present address: Lehrstuhl fü r Bioinformatik, Biozentrum der Universität Wü rzburg, D-97074 Wü rzburg, Germany. This paper is dedicated to Professor Dr Ferdinand Radler on the occasion of his 75th birthday.
Abbreviations: GFP, green fluorescent protein; GPI, glycosylphospatidylinositol. respect to its function in cell wall assembly and composition. The presented data imply a structural, rather than enzymic, function of yeast Kre1p within cell wall b-1-6-glucan assembly and architecture.
METHODS
Yeast strains and culture conditions. S. cerevisiae Kre1 + and Kre1 2 strains SEY6210 (MATa leu2-3 his3-D200 lys2-801 trp1-D901 suc2-D9) and SEY6210 [Dkre1] (MATa leu2-3 his3-D200 lys2-801 trp1-D901 suc2-D9 kre1 : : HIS3) were kindly provided by Howard Bussey (McGill University, Montreal, Canada) . The gpi mutant strains 2A (MATa ade2-101 ura3-52 his4 gpi1), 27-5D (MATa ade2-101 ura3-52 gpi2), 53-12C (MATa lys2 gpi3) and its parental GPI1 wild-type strain 37-10C (MATa ade2-101 ura3-52) were kindly provided by Peter Orlean (University of Illinois, Urbana, USA). The mnn2 mutant strain X2180-m2-1a (MATa suc2 mal gal2 CUP1 mnn2) was kindly provided by Clinton Ballou (University of California, Berkeley, USA). Cells were grown in YEPD medium at 30 uC. Transformation was carried out by the lithium acetate method described by Ito et al. (1983) and transformants were selected on synthetic complete (YNB) medium lacking uracil.
The K1 and K28 toxins were prepared as described by Pfeiffer & Radler (1982) and Schmitt & Tipper (1990) using S. cerevisiae strains T158C and MS300b, respectively, as toxin producer. Zygocin was prepared from the Zygosaccharomyces bailii killer strain 412 essentially as previously described (Radler et al., 1993; Weiler & Schmitt, 2003) . In brief, the corresponding killer yeast was grown at 20 uC in synthetic B-medium (pH 4?7 for K1 and K28, pH 4?0 for zygocin). After entering the stationary growth phase, cells were pelleted by centrifugation and the cell-free culture supernatant was concentrated 1000-fold by ultrafiltration using a Sartorius ultrafiltration system (SM 16525) and trifluoracetate membranes with a molecular mass cut-off of 10 kDa. The biologically active toxins were filter-sterilized and kept frozen at 220 uC. Toxin activity was determined in a standard killing-zone assay as decribed previously and toxin activity is expressed in arbitrary units (Schmitt & Tipper, 1990) .
For spheroplast preparation, the appropriate yeast was cultivated at 30 uC in YEPD medium until late exponential growth phase (5610 7 cells ml 21 ), harvested and washed twice with sterile water. Cells were resuspended in Tris/HCl buffer (0?1 M Tris/HCl, pH 8?0, 5 mM DTT, 5 mM EDTA), incubated at 30 uC for 30 min and washed twice in 1?2 M sorbitol. Washed cells were finally resuspended in 1?2 M sorbitol containing 0?5 M Na 2 HPO 4 and yeast cell spheroplasts were generated by zymolyase 20T treatment (Schmitt & Tipper, 1990) .
Escherichia coli strains, plasmids and DNA manipulations.
Standard molecular manipulations were performed as described by Sambrook et al. (1989) . For cloning, E. coli strain DH5a [F 2 recA1 endA1 gyrA96 thi hsdR17 supE44 relA1 D(argF-lacZYA)U169 (w80dlacZDM15) l 2 ] was used. All Kre1p expression plasmids used in this study are derivatives of the episomal 2m vector pPGK-M28-I (Schmitt & Tipper, 1995) in which the entire K28 pptox open reading frame (M28) was replaced by the indicated KRE1 gene fusion and placed under transcriptional control of the constitutive PGK1 promoter .
Extraction of cell wall mannoproteins. Crude cell wall mannoproteins were extracted using a method according to Nakajima & Ballou (1974a, b) modified as previously described (Schmitt & Radler, 1987) . Briefly, cells were cultivated at 30 uC in YEPD containing 5 % glucose until late exponential growth phase, harvested and washed three times with sterile water. Cells were resuspended in 20 mM citrate/phosphate buffer (pH 7?0; 1 ml cell suspension per g wet weight of cells) and autoclaved for 90 min at 121 uC. After centrifugation the pellet was resuspended in 20 mM citrate/phosphate buffer and autoclaved again. This procedure was repeated and the supernatants were pooled. After the addition of 3 vols ice-cold ethanol, the obtained crude mannoprotein precipitate was pelleted at 4 uC, resuspended in 70 ml extraction buffer and dialysed overnight against deionized water. The amount of mannoprotein was determined after lyophilization. For partial purification of the crude mannoproteins, a cetavlon fractionation was carried out by the method of Lloyd (1970) . The crude mannoprotein was dissolved in double-distilled water (25 ml g 21 ) and combined with a solution of 1 g cetavlon (cetyl-N,N,N-trimethyl-ammonium bromide) in 10 ml double-distilled water. After stirring for 1 h at 20 uC, the precipitate was pelleted and washed with 50 ml distilled water. In order to precipitate cell wall mannoproteins as a boric acid complex, the pooled supernatants were acidified by the addition of 100 ml boric acid (1 %) and the pH was adjusted to pH 8?8 by the addition of 2 M NaOH. The resulting complex was pelleted, washed twice with sodium acetate (0?5 %, pH 8?8) and resuspended in acetate (0?5 %). Another precipitation was performed by the addition of 1 g solid sodium acetate and 3 vols ethanol. The precipitate was pelleted, washed twice with acetate (2 % in ethanol), and resuspended in double-distilled water. After neutralization with 2 M NaOH and subsequent dialysis against 200 vols of distilled water, the cetavlon mannoprotein was maintained and lyophilized for performing further studies.
Adsorption of killer toxins K1 and K28 to cetavlon mannoprotein -in vivo competition assay. Cetavlon mannoproteins were resuspended at concentrations from 1 to 10 mg ml 21 in 880 ml B-medium, pH 4?7 (Pfeiffer & Radler, 1982) . Each sample also contained 20 ml of the appropriate killer toxin (about 10 4 U ml 21 ) and 100 ml of S. cerevisiae SEY6210 with a cell concentration of about 10 7 cells ml 21 . After incubation of the samples for 24 h with gentle shaking at 20 uC, colony-forming units of the sensitive strain were determined by plating a range of dilutions onto YEPD agar, pH 7?0. The remaining toxin in the samples was rapidly inactivated due to the high pH of the agar. Competition assays were performed according to the methods of Hutchins & Bussey (1983) and Schmitt & Radler (1987) , with S. cerevisiae 518 as sensitive test strain.
Immunoblot analysis. After transformation with the indicated Kre1p expression construct, approximately 2610 7 yeast cells were grown either at the permissive (20 uC) or at the semi-restrictive (25 uC) temperature in minimal medium under conditions of plasmid selection. Cells were harvested and the extracellular proteins secreted into the cell-free culture medium were concentrated by ethanol precipitation and incubated overnight at 220 uC. Protein samples were resuspended in water and separated by Tricine-SDS-PAGE according to the method of Schagger & von Jagow (1987) . After electrotransfer of the proteins onto a nitrocellulose membrane, blots were incubated with a monoclonal anti-GFP (green-fluorescentprotein) antibody (Roche; diluted 1/10 000) followed by treatment with an alkaline phosphatase-coupled anti-rabbit antibody (Sigma; diluted 1/3000), and developed with NBT/BCIP (Roche).
Preparation of cell wall 1,6-b-D-glucan. 1,6-b-D-Glucan was isolated and quantified as described by Boone et al. (1990) . In brief, yeast cells were cultivated in SC medium (or the appropriate D/Omedium if plasmid selection was required) until stationary growth phase. Cells were harvested, washed twice with distilled water and then extracted three times with 0?5 ml 3 % NaOH at 75 uC (1 h per extraction) to remove alkali-soluble glucan and mannoproteins. After alkali extraction, cells were neutralized and washed by the addition of 1 ml 0?1 mM Tris/HCl (pH 7?5) and 1 ml 10 mM Tris/ HCl (pH 7?5). Washed cells were resuspended in 1 ml 10 mM Tris/ HCl (pH 7?5) containing 5 mg zymolyase 20T (ICN Biomedicals) Downloaded from www.microbiologyresearch.org by IP: 54.70.40.11
On: Thu, 27 Dec 2018 00:06:11 and incubated overnight at 37 uC. After digestion of the cell wall, the insoluble cell pellet was removed by centrifugation (13 000 r.p.m., 15 min) and the supernatant was dialysed against distilled water. Analysis of the carbohydrate retained after dialysis yielded the proportion of alkali-insoluble 1,6-b-glucan. Total carbohydrate in each fraction was measured as hexose by the phenol/sulfuric acid method of Dubois et al. (1956) . Each experiment was repeated at least three times.
RESULTS
The length of Kre1p affects the total amount of alkali-insoluble cell wall 1,6-b-glucan By expressing an N-terminal-truncated derivative of Kre1p in a yeast Dkre1 null mutant we recently showed that Kre1p functions as a plasma membrane receptor for the yeast K1 virus toxin . Here, we investigated the influence of this truncation on its in vivo function in latestage 1,6-b-D-glucan assembly.
We and others have previously shown that K1 toxin resistance of a yeast Dkre1 mutant is due to a block in the initial interaction of the toxin with the yeast cell surface, and that susceptibility can be restored by retransformation with the wild-type KRE1 gene. This observation implies that expression of wild-type Kre1p not only increases the 1,6-bglucan content of the disruption mutant up to wild-type level, but also restores toxin binding to the cytoplasmic membrane. In order to investigate the effect of Kre1p on cell wall glucans in more detail, we determined the amount of alkali-insoluble 1,6-b-D-glucan in a Dkre1 null mutant before and after expression of either full-length Kre1p or its N-terminally truncated derivative D 1-225 Kre1p. As summarized in Table 1 , the 1,6-b-glucan level in the null mutant compared to the wild-type was diminished by 33 %, thus confirming earlier reports of Boone et al. (1990) . As expected, expression of D 1-225 Kre1p did not restore 1,6-bglucan levels, while expression of full-length Kre1p did, indicating that the N-terminal part of Kre1p is responsible for its function in 1,6-b-glucan assembly. The slightly increased 1,6-b-glucan content seen in the Dkre1 mutant after expression of the full-length protein Kre1p is likely to be caused by its multi-copy expression from the strong PGK1 promoter.
Deletion of KRE1 affects cell wall mannoprotein composition
Since deletion of KRE1 results not only in K1-but also in K28-toxin resistance, we investigated the response of a Dkre1 knock-out mutant to K28 in more detail. Killing-zone assays showed that intact cells of the Dkre1 mutant were likewise K1 and K28 resistant (Table 2) . However, at the plasma membrane level, studied using spheroplasts, the mutant remained K1 toxin-resistant but showed pronounced sensitivity to K28 (Table 2) . This unique phenotypic response of Dkre1 spheroplasts to K1 and K28 implies the existence of two different toxin receptor populations for K1 and K28 within the cytoplasmic membrane. Interestingly, intact cells of the Dkre1 mutant remained sensitive to the Z. bailii virus toxin zygocin, although this toxin -like K28 -specifically binds to cell wall mannoproteins as the primary zygocin receptor (see Table 3 ; Radler et al., 1993; Weiler & Schmitt, 2003) . This observation indicates that the reduced amount of 1,6-b-glucan seen in the Dkre1 mutant might also affect the expression of certain mannoproteins at the cell surface, in particular those cell wall mannoproteins that contain 1,3-a-mannotriose outer sidechains. In the case of K28 it is known that toxin binding to the cell wall receptor critically depends on the length of the outer mannoprotein side-chains and particularly requires the presence of a-1,3-linked mannotriose side-chains (Schmitt & Radler, 1988) . In contrast, the exact mannoprotein binding site for the Z. bailii virus toxin zygocin has not yet been identified. Thus, in a yeast Dkre1 mutant, whole-cell sensitivity to zygocin and resistance to K28 might be caused by the absence of or reduction in certain 1,3-amannotriose-containing cell surface mannoproteins which in turn prevent K28 toxin binding without affecting cell wall binding of zygocin.
To investigate K28 toxin resistance in intact cells of the Dkre1 knock-out mutant, mannoproteins were isolated and partially purified from cell walls of Kre1 2 and Kre1 + strains. A K28-resistant mannoprotein mutant (mnn2) was included as a control. In comparison to the KRE1 wildtype, the Dkre1 mutant showed only a slight decrease in the overall content of cell wall mannoproteins (33 and 28 mg per g wet weight, respectively) while in the yeast mnn2 mutant, mannoproteins were more severely reduced (23 mg per g wet weight). However, the moderate decrease in cell wall mannoprotein content observed in the Dkre1 mutant could not be seen by SDS-PAGE and periodic acid-Schiff staining: both electrophoretic mobility and glycoprotein staining intensity of the isolated high-molecular-mass cell wall mannoproteins (>180 kDa) were indistinguishable in the Dkre1 mutant and its isogenic Kre1 + wild-type (data not shown). This indicates a more qualitative change in mannoprotein composition, rather than a simple reduction in the overall mannoprotein content.
The capacity of the isolated mannoproteins to adsorb K1 as well as K28 was also determined. Mannoprotein fractions of the Dkre1 disruption mutant showed a decreased adsorption of K28 compared to wild-type, confirming the above-mentioned assumption that cell surface mannoproteins containing 1,3-a-mannotriose outer side-chains, which are responsible for K28 toxin binding in vivo and in vitro, are either missing or somehow under-represented in the genetic background of a Dkre1 null mutation (Fig. 1) . Interestingly, isolated and partially purified cell wall mannoproteins could also adsorb significant amounts of K1 toxin, indicating that the mannoprotein fraction still contains 1,6-b-D-glucans. Thus, our data are consistent with observations of Kapteyn et al. (1996) and Kollar et al. (1997) that cell wall mannoproteins are embedded in a heteropolymeric matrix consisting of 1,3-b-and 1,6-bglucans. Whereas isolated mannoproteins from an mnn2 mutant did not bind significant amounts of K28, they were still capable of binding to K1 toxin in a similar manner as Mnn2 + cells; this again implies that 1,6-b-glucan synthesis is not negatively affected in the mnn2 mutant.
Function of the C-terminal hydrophobic stretch of Kre1p
In Kre1p, the 21 amino acid hydrophobic tract at the Cterminus either serves as a recognition sequence for the attachment of a GPI anchor or simply acts as a transmembrane domain. Roemer & Bussey (1995) failed to demonstrate a possible GPI-anchoring of Kre1p by labelling the GPI moiety with myo-[ 3 H]inositol or by releasing Kre1p from the membrane by treatment with phosphatidylinositolphospholipase C. To investigate the membrane anchorage of Kre1p in more detail, we phenotypically characterized a set of yeast gpi mutants (gpi1, gpi2, gpi3) which are defective in GPI anchor biosynthesis of various yeast plasma membrane and cell wall proteins due to an early block in N-acetylglucosaminyl-phosphatidylinositol (GlcNAc-PI) synthesis, a central metabolic intermediate within the first step of GPI anchor assembly (Leidich et al., 1994 (Leidich et al., , 1995 Leidich & Orlean, 1996) . If GPI-anchoring of Kre1p was dependent on Gpi1p, Gpi2p and/or Gpi3p, then K1 sensitivity of the corresponding gpi mutant should decrease when mutant cells are shifted from the permissive to the semi-restrictive temperature, due to a diminished incorporation of Kre1p into the plasma membrane and -because of the function of Kre1p in cell wall 1,6-b-D-glucan assembly -a decrease in cell wall 1,6-b-D-glucan content. The gpi mutants and the isogenic GPI wild-type were incubated at the permissive (20 u C) and at the semi-restrictive (25 u C) temperatures and subsequently tested for K1 sensitivity. To check that the toxin remained stable throughout the experiment, the sensitive tester strain SEY6210 was also included as control. As shown in Fig. 2 , the GPI wild-type strain 37-10C and its isogenic gpi2 and gpi3 mutants as well as the positive control strain SEY6210 were equally sensitive to K1 at both temperatures (20 uC and 25 uC) and showed only a moderate loss in K1 sensitivity at the elevated temperature; thus, temperature stability of K1 at 25 u C is confirmed. In contrast, gpi1 mutant cells showed a significant decrease in K1 sensitivity after shift to the semirestrictive temperature (25 u C), strongly indicating an essential involvement of GPI1 in GPI-anchoring of Kre1p in vivo. The fact that such a phenotype was not detectable in the gpi2 nor in the gpi3 mutant is likely to be caused by differences in the temperature-sensitive (ts) phenotype of the corresponding gpi1,2,3 ts alleles. While gpi1 ts mutant cells showed the expected block in GPI-anchoring already at the semi-restrictive temperature of 25 uC, this temperature was too low to see a phenotype in the gpi2/3 ts mutants. Since cell growth and viability of both mutants (gpi2/3 ts ) was severely impaired at temperatures above 25 u C, and K1 activity is greatly reduced by prolonged incubation at elevated temperatures, K1 toxin sensitivity could not be determined under the restrictive culture conditions at which gpi2/3 ts mutants are blocked in GPI-anchoring.
Interestingly, the amount of alkali-insoluble cell wall 1,6-bglucan was equal at both temperatures in the gpi1 mutant (data not shown). It therefore can be concluded that the function of Kre1p in 1,6-b-glucan synthesis and/or assembly is not negatively affected when GPI anchoring of Kre1p is at least partially functional, although its essential role in K1 . K1 toxin sensitivity in yeast gpi mutants and the isogenic Gpi1 + wild-type after growth under permissive (20 6C) or semi-restrictive (25 6C) culture conditions. S. cerevisiae gpi mutant strains 2A (gpi1), 27-5D (gpi2) and 53-12C (gpi3) as well as the parental Gpi + wild-type strain 37-10C were incubated at the indicated temperature and K1 sensitivity was determined by the killing-zone assay as described in the Methods. S. cerevisiae SEY6210 (Gpi1 + ) was used as a positive control to check for K1 toxin stability at 25 6C. K1 sensitivity, determined by pipetting 10 4 units K1 toxin into wells of a methylene blue agar plate (pH 4?7) and incubating for 3 days at 20 6C, is expressed as percentage of K1 sensitivity at 25 6C in comparison to K1 sensitivity at the permissive temperature (100 %).
lethality of mediating toxin binding to the plasma membrane is completely lost.
To further confirm that GPI-anchoring is necessary for the in vivo targeting of Kre1p and its subsequent incorporation into the wall, the gpi1 mutant was transformed with a plasmid expressing a GFP-tagged derivative of Kre1p and subsequently examined for secretion of the K28/GFP/Kre1p fusion into the culture medium before and after shifting the cells to the semi-restrictive temperature. As illustrated in Fig. 3 , a signal for the secreted K28/GFP/Kre1p fusion was detectable in the culture supernatant of cells grown at 25 uC, but not at the permissive temperature, confirming that GPI1 is involved in the transient GPI-anchoring of Kre1p.
Kre1p variants lacking a GPI-anchoring signal cannot complement a Dkre1 mutation
In yeast, GPI-anchored plasma membrane and cell wall proteins contain a conserved v-site near their C-terminal end which signals GPI anchor addition in the endoplasmic reticulum (Caro et al., 1997; de Groot et al., 2003) . In Kre1p, such a motif is located at amino acid position 286 (Fig. 4) .
To further demonstrate that the in vivo GPI-anchoring of Kre1p is necessary for both K1 toxin binding to the yeast cell surface and cell wall 1,6-b-glucan assembly, four different C-terminally truncated Kre1p derivatives were constructed which all lacked the GPI attachment site and only differed in the length of their intramolecular serine/threonine-rich spacer sequence (Fig. 4) . Interestingly, after in vivo expression in a yeast Dkre1 mutant, only wild-type Kre1p but none of its C-terminally truncated derivatives was capable of complementing the Dkre1 null mutation and restoring cell wall 1,6-b-D-glucan (Fig. 4) . Thus, although the trun- (1991) . The box on the left shows the phenotypes of the indicated Kre1p derivatives which were determined on the basis of cell wall 1,6-b-D-glucan and wholecell K1 toxin sensitivity after expression in a yeast Dkre1 null mutant. +++, wild-type 1,6-b-D-glucan (corresponding to 84 mg alkali-insoluble glucan per mg dry weight cell wall; see also Table 1) ; ", significantly reduced cell wall 1,6-b-D-glucan (40-50 % of Kre1 + wild-type); +++, wild-type K1 toxin sensitivity; ++, reduced K1 sensitivity; +, greatly reduced K1 sensitivity; ", K1 toxin resistance; ND, not determined.
progressively shortened without altering or deleting its C-terminal GPI attachment site, the corresponding Nterminally truncated Kre1p derivative retains considerable partial function in complementing a Dkre1 null mutation (Boone et al., 1991; Fig. 4 ). It therefore can be concluded that Kre1p, in its GPI-anchored and plasma membranebound forms, is not only essential for its in vivo function as a K1 membrane receptor but also for ensuring wild-type cell wall 1,6-b-D-glucan content, indicating a more structural role of Kre1p in yeast cell wall assembly and architecture.
DISCUSSION
Recently, the involvement of Kre1p in the initial binding of the K1 virus toxin to the plasma membrane of a sensitive target cell was demonstrated, and it was shown that K1 toxin binding to the cell wall of a yeast Dkre1 null mutant can only be restored by expressing the full-length Kre1p protein, not the N-terminally truncated derivative D 1-225 Kre1p . We now extend these findings by showing that in a Dkre1 mutant, expression of wild-type Kre1p (in contrast to its N-terminally truncated derivative) enhances the amount of cell wall 1,6-b-glucans up to wild-type level. The observation of Boone et al. (1990) that the kre1 disruption mutant shows a 40 % diminished amount of alkali-insoluble 1,6-b-glucan in the cell wall could be confirmed in our studies. In agreement with the phenotype observed in the toxin sensitivity/resistance assays, expression of D 1-225 Kre1p did not increase the overall 1,6-b-glucan content of the cell wall, whereas expression of wild-type Kre1p did. This indicates that the N-terminal part of Kre1p (including its serine/threoninerich segment) is responsible for the observation of Boone et al. (1990) that the 1,6-b-glucan fraction isolated from cell walls of a Dkre1 mutant has an altered structure with a lower mean polymer size and fewer b-1,6-linked side-chains than the corresponding glucan of a Kre1 + wild-type. It has been speculated that Kre1p mediates the addition of linear side-chains of b-1,6-linked glucose units to a highly branched b-1,6-and b-1,3-linked glucan backbone (Boone et al., 1990) . However, so far it is not known how this addition occurs, and the question arises whether this function of Kre1p is a structural or an enzymic one. Boone et al. (1991) have shown that deletions in the non-conserved serine/threonine-rich region of Kre1p led to a progressive loss in K1 sensitivity as the deletion increased in size, ending up with complete K1 resistance when the conserved coding region was absent. In the N-terminally truncated protein (D 1-225 Kre1p), this conserved region is completely removed, leading to the inability of the fusion to restore its function in 1,6-b-glucan assembly and consequently causing a severe defect in K1 toxin binding to the outer surface of a Dkre1 mutant cell.
Moreover, the observed K1/K28 cross-resistance at the cell wall level in a yeast Dkre1 mutant suggests that resistance to K28 toxin can be attributed to the decreased amount of cell wall mannoproteins which represent the primary toxin receptors for K28 (Schmitt & Radler, 1988) . This finding is consistent with data from Kapteyn et al. (1997) and Kollar et al. (1997) showing that a major group of mannoproteins is covalently anchored in the cell wall by 1,6-b-glucans. Furthermore, it has been reported that severe 1,6-b-glucan defects in several kre mutants lead to the secretion of certain cell wall mannoproteins, e.g. a-agglutinin (Lu et al., 1995) . This result is somewhat contradictory to that of Hutchins (1982) , who found that kre1 mutants do not show a significant reduction in total cell wall mannoproteins. Our data confirm the latter observation since deletion of KRE1 did not significantly decrease the overall amount of mannoproteins. The regained K28 toxin sensitivity of the Dkre1 mutant after removal of the cell wall demonstrates the existence of two different receptor populations for the toxins K1 and K28 at the level of the cytoplasmic membrane, as formerly speculated by Schmitt & Compain (1995) . This is also confirmed by more recent studies in which it was shown that soon after K28 has bound to the cell wall, the toxin is taken up by receptor-mediated endocytosis and traverses the secretion pathway in reverse, and finally dislocates into the cytosol, where K28-a transmits the cytotoxic signal into the nucleus (Schmitt & Eisfeld, 1999; Eisfeld et al., 2000) .
However, the cell wall receptor of the Z. bailii virus toxin zygocin, which is also a cell wall mannoprotein (see Table 3 ), is still present in the Dkre1 mutant, indicating that the normal composition of cell wall mannoproteins is somehow altered in a Kre1 2 genetic background. Since isolated mannoproteins from a Dkre1 mutant showed a significantly decreased K28 toxin binding when tested in an in vivo competition experiment, it can be speculated that the serine/threonine-rich region of Kre1p is responsible for ensuring wild-type levels of those cell wall mannoproteins which contain 1,3-a-mannotriose outer sidechains that function as primary K28 toxin receptors (Schmitt & Radler, 1988) . This would suggest a more structural function of Kre1p in linking certain mannoproteins of the cell surface to cell wall glucans. The observation that a haemagglutinin-tagged derivative of Kre1p mainly localizes to the cell wall likewise supports a more structural role of Kre1p, but an enzymic function of Kre1p after its transfer to and incorporation into the wall is unlikely (Roemer & Bussey, 1995) . This speculation is further supported by recent work of Terashima et al. (2003) , who showed that changing the normal localization of a GPI-associated yeast protein from the plasma membrane to the cell wall greatly affects its cellular function.
Taken together, the data presented in this study argue against an enzymic function of Kre1p and rather suggest a more structural role within the formation of the cell wall network, possibly by being somehow involved in covalently cross-linking 1,6-b-glucans to other cell wall components such as 1,3-b-glucan, chitin and certain mannoproteins (Fig. 5 ). Roemer & Bussey (1995) could not detect any covalently attached 1,6-b-glucan by using a 1,6-b-glucan antiserum and furthermore observed that Kre1p expressed in a kre5 mutant (which lacks detectable 1,6-b-glucan) shows the same electrophoretic mobility as in a Kre + wildtype background. However, the inability to detect 1,6-bglucan immunologically is not a definitive proof. In a similiar manner, this phenomenon was previously ascribed to a peculiar cell wall structure of certain proteins as reported for Cwp2p (van der Vaart et al., 1996) . The lack of a mobility shift of Kre1p expressed in a kre5 mutant could be due to changes to the composition within the cell wall, which is a known compensatory yeast response to a variety of internal and external stress factors (Ram et al., 1998) , but again this would not exclude a structural function of Kre1p. Montijn et al. (1999) demonstrated that 1,6-b-glucan synthesis takes place at the cell surface, suggesting that Kre1p is not associated with 1,6-b-glucan during its passage through the secretory pathway but rather receives some so far unknown modification which could be required for its proper structural function later on. In another explanation, Kre1p expressed in a kre5 mutant could be incorporated into the wall by cross-linking other cell wall components such as 1,3-b-glucan or chitin. The fact that digests of cell wall preparations did not release significant amounts of Kre1p could be due to unusual post-translational processing of Kre1p within the secretory pathway as speculated by Roemer & Bussey (1995) . An unusual modification such as this could be the main reason for embedding the protein as a 1,3-b-glucanase-resistant structural component into the wall, as was recently described for Gas1p (De Sampaio et al., 1999) . However, our data suggest that Kre1p might be directly involved in cross-linking certain mannoproteins of the cell surface as indicated by the unique sensitivity profile observed for the killer toxins K28 and zygocin (see Table 2 ).
The C-terminal hydrophobic stretch of Kre1p is thought either to serve as a transmembrane domain which anchors the protein in the plasma membrane or to be responsible for the processing of Kre1p (Roemer & Bussey, 1995) . During this processing, the protein could initially be membrane-associated, and subsequently targeted to the membrane via a GPI anchor and finally incorporated into the wall after GPI anchor processing and splitting via a so far unknown transglycosylation reaction between the remaining phosphoethanolamine and several mannosyl residues on the 1,6-b-glucan of the cell wall ( Fig. 5 ) . Recently, we found evidence for a membrane-bound form of Kre1p whose slight increase in size reflects and portrays the presence of a GPI anchor . Here, we have extended and confirmed these findings by investigating a gpi1 mutant expressing a GFP-tagged Kre1p derivative. Interestingly, a significant decrease in K1 sensitivity was observed in a gpi1 mutant, strongly indicating that Gpi1p is involved in the anchoring of Kre1p during its passage through the yeast secretory pathway. Even when cultivated at the semi-restrictive temperature (25 uC), a significant amount of a K28/GFP/ Kre1p fusion protein was secreted into the culture medium of the gpi1 mutant, although apparently the remaining Kre1p was still incorporated into the wall and was sufficient to ensure wild-type 1,6-b-glucan levels. Nevertheless, the remaining amount of Kre1p at the yeast cell surface was not sufficient to ensure K1 toxin binding or to confer K1 sensitivity. Together with the increased size of the membrane-bound form of the K28/GFP/Kre1p fusion, these data provide further evidence for an at least transient GPI-anchoring of Kre1p, in which form it also acts as membrane receptor for the yeast K1 virus toxin . Interestingly, the essential function of the in vivo GPI anchoring of Kre1p was even more pronounced in Kre1p variants that lacked a C-terminal GPI attachment site: Kre1p variants in which the v-site had been deleted were not capable of complementing a Dkre1 null mutation and neither did they restore cell wall 1,6-b-D-glucan content.
The precise function of Kre1p in the in vivo synthesis and assembly of cell wall 1,6-b-glucan has still to be elucidated. However, the observation here of a slight decrease in cell wall mannoprotein content and an altered or reduced amount of cell surface mannoproteins containing 1,3-a-mannotriose outer side-chains in a yeast Dkre1 mutant may be a useful basis upon which to further investigate the protein's function, especially if Kre1p were to be involved somehow Based on the data presented in this study, GPI-anchored Kre1p is proposed to be involved in the cross-linking of cell wall 1,6-b-D-glucan and certain cell surface mannoproteins containing 1,3-a-mannotriose outer side-chains. Incorporation of Kre1p into the cell wall is thought to occur after GPI-anchor processing followed by a so far unknown transglycosylation reaction (indicated by ?) in which the GPImoiety of Kre1p is cleaved and a new glycosidic link is formed with 1,6-b-glucan. While cell wall 1,6-b-D-glucan serves as the primary K1 toxin receptor, 1,3-a-mannotriose side-chains of cell wall mannoproteins represent the primary binding sites for the K28 virus toxin. In its transient GPI-anchored form, Kre1p also functions as the K1 plasma membrane receptor. Cross-linking of chitin and 1,3-b-D-glucan to 1,6-b-D-glucan, originally described by Kapteyn et al. (1997) and Kollar et al. (1997) , was incorporated into this model (see text for details). CM, cytoplasmic membrane; CW, cell wall.
in cross-linking of certain mannoproteins and cell wall 1,6b-glucan. Additional experiments will be required to show if our current model of Kre1p in vivo function (as presented in Fig. 5 ) holds true; we intend to address this aspect in the near future.
